Percentage of CD3+CD4-CD8-γδTCR- T cells is increased by HIV disease

被引:17
作者
Mathiot, ND
Krueger, R
French, MA
Price, P
机构
[1] Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA 6001, Australia
[2] Univ Western Australia, Dept Pathol, Perth, WA 6001, Australia
关键词
D O I
10.1089/088922201750290096
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV patients given highly active antiretroviral therapy (HAART) experience a rapid rise in alpha betaT cell numbers, but changes in gamma deltaT cell populations have not been described. Here we investigate the effects of immune reconstitution and immune restoration diseases (IRDs) on expression of a pan-gamma deltad T cell receptor (TCR) marker on double-negative (CD3(+)CD4(-)CD8(-)) T cells and T cells expressing CD4 or CD8. IRDs are inflammatory disorders associated with preexisting infections in patients who have achieved immune reconstitution after HAART. Proportions of CD3(+)CD4(-)CD8(-) T cells and total gamma deltaT cells were not affected by CD4(+) T cell counts, HAART, or a history of IRD, but levels of CD4(-)CD8(-)gamma delta TCR- T cells were higher in patients with <15% CD4(+) T cells.
引用
收藏
页码:977 / 980
页数:4
相关论文
共 19 条
[1]  
Beckman EM, 1996, J IMMUNOL, V157, P2795
[2]   Major expansion of γδ T lymphocytes following cytomegalovirus infection in kidney allograft recipients [J].
Déchanet, J ;
Merville, P ;
Bergé, F ;
Bone-Mane, G ;
Taupin, JL ;
Michel, P ;
Joly, P ;
Bonneville, M ;
Potaux, L ;
Moreau, JF .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :1-8
[3]   INVIVO PERSISTENCE OF EXPANDED CLONES SPECIFIC FOR BACTERIAL-ANTIGENS WITHIN THE HUMAN T-CELL RECEPTOR-ALPHA-BETA CD4-8- SUBSET [J].
DELLABONA, P ;
CASORATI, G ;
FRIEDLI, B ;
ANGMAN, L ;
SALLUSTO, F ;
TUNNACLIFFE, A ;
ROOSNEEK, E ;
LANZAVECCHIA, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1763-1771
[4]   DIFFERENTIAL PRODUCTION OF INTERFERON-GAMMA AND INTERLEUKIN-4 IN RESPONSE TO TH1-STIMULATING AND TH2-STIMULATING PATHOGENS BY GAMMA-DELTA T-CELLS IN-VIVO [J].
FERRICK, DA ;
SCHRENZEL, MD ;
MULVANIA, T ;
HSIEH, B ;
FERLIN, WG ;
LEPPER, H .
NATURE, 1995, 373 (6511) :255-257
[5]  
French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x
[6]   ZIDOVUDINE-INDUCED RESTORATION OF CELL-MEDIATED-IMMUNITY TO MYCOBACTERIA IN IMMUNODEFICIENT HIV-INFECTED PATIENTS [J].
FRENCH, MAH ;
MALLAL, SA ;
DAWKINS, RL .
AIDS, 1992, 6 (11) :1293-1297
[7]  
Garcia VE, 1997, J IMMUNOL, V159, P1328
[8]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733
[9]   Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? [J].
John, M ;
Flexman, J ;
French, MAH .
AIDS, 1998, 12 (17) :2289-2293
[10]   Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy [J].
Karavellas, MP ;
Plummer, DJ ;
Macdonald, JC ;
Torriani, FJ ;
Shufelt, CL ;
Azen, SP ;
Freeman, WR .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) :697-700